Crinetics Pharmaceuticals
CRNX
CRNX
122 hedge funds and large institutions have $993M invested in Crinetics Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 45 increasing their positions, 37 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding
Funds holding: 122 → 122 (0)
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
0% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 13
Holders
122
Holding in Top 10
7
Calls
$43K
Puts
$20K
Top Buyers
| 1 | +$15.1M | |
| 2 | +$6.79M | |
| 3 | +$4.64M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$3.59M |
| 5 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$3.26M |
Top Sellers
| 1 | -$23.5M | |
| 2 | -$17.2M | |
| 3 | -$14.6M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$14.4M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$2.91M |